Watch DNTH. Know when insiders buy.
One email the day a filing lands. Free.
DNTH
Dianthus Therapeutics, Inc. /DE/
78.10
−0.65 −0.83%
USD · close Oct 21
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
38
FLAG · insiders 25, shorts 50
Insiders, 90 days
−$4.5M
net selling · 0 buys, 8 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $4.4BP/E —DIV YIELD —FCF YIELD -3.56%REV TTM —NET INCOME −$192.2MNET CASH —52W 32.92 – 115.96SEC XBRL · TTM TO Invalid Date
Insider trading
−$4.5M
Net, 90 days
0 / 8
Buys / sells, 90 days
0
Distinct buyers
$0
Bought, 90 days
| Traded | Filed | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 17 | Sep 18 | CARR EDWARD · CHIEF ACCOUNTING OFFICER | Sell | 700 | $104.39 | $73K |
| Sep 17 | Sep 18 | CARR EDWARD · CHIEF ACCOUNTING OFFICER | Sell | 1,100 | $103.20 | $114K |
| Sep 17 | Sep 18 | CARR EDWARD · CHIEF ACCOUNTING OFFICER | Sell | 3,501 | $102.39 | $358K |
| Sep 17 | Sep 18 | CARR EDWARD · CHIEF ACCOUNTING OFFICER | Sell | 6,771 | $101.37 | $686K |
| Sep 17 | Sep 18 | CARR EDWARD · CHIEF ACCOUNTING OFFICER | Sell | 7,928 | $100.43 | $796K |
| Sep 1 | Sep 3 | Randhawa Simrat · EVP, Head of R&D | Sell | 13,309 | $106.74 | $1.4M |
| Sep 1 | Sep 3 | Randhawa Simrat · EVP, Head of R&D | Sell | 7,215 | $106.25 | $767K |
| Sep 1 | Sep 3 | Randhawa Simrat · EVP, Head of R&D | Sell | 2,600 | $105.19 | $273K |
Source: SEC EDGAR Form 4 filings, pulled nightly; open-market purchases and sales only, no option exercises or grants. The tracker, all tickers.